SIMCERE PHARMA (02096) spent 10.1667 million Hong Kong dollars to repurchase 1.49 million shares on November 18th.
Sinopharm (02096) announced that on November 18, 2024, the company invested 1016.67 million...
SIMCERE PHARMA (02096) announced that on November 18, 2024, the company repurchased 1.49 million shares at a cost of 10.167 million Hong Kong dollars. The repurchase price was between 6.71 and 6.98 Hong Kong dollars per share.
Related Articles
US Stock Market Move | General Motors Company (GM.US) rises over 3%, returning to the missile supply chain after nearly 29 years.
US Stock Market Move | Gold and silver, non-ferrous metals concept stocks broadly rise; Pan American Silver Corp. (PAAS.US) gains over 4%.
GENSCRIPT BIO (01548): Share price and trading volume have risen, and the Company has entered into a collaboration with Lilly TuneLab.
US Stock Market Move | General Motors Company (GM.US) rises over 3%, returning to the missile supply chain after nearly 29 years.
US Stock Market Move | Gold and silver, non-ferrous metals concept stocks broadly rise; Pan American Silver Corp. (PAAS.US) gains over 4%.
GENSCRIPT BIO (01548): Share price and trading volume have risen, and the Company has entered into a collaboration with Lilly TuneLab.
RECOMMEND
